Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 20-Dec-23 4:33 PM View:  | BioCryst Pharmaceuticals Inc. (BCRX) | 19-Dec-23 | Payment of Exercise | 2,482 | $6.05 | $15,016.10 | (< 1%) 296.02K to 293.54K | |
| 18-Dec-23 4:34 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 14-Dec-23 | Grant | 64,000 | -- | -- | 27% 236.04K to 300.04K | |
| 18-Dec-23 4:34 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 14-Dec-23 | Payment of Exercise | 4,015 | $6.43 | $25,816.40 | (1%) 300.04K to 296.02K | |
| 21-Dec-22 4:43 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 19-Dec-22 | Grant | 34,000 | -- | -- | 17% 198.77K to 232.77K | |
| 19-Dec-22 4:38 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 15-Dec-22 | Sale | 4,175 | $10.88 | $45,424.00 | (2%) 202.94K to 198.77K | |
| 16-Dec-21 5:03 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 14-Dec-21 | Grant | 75,000 | -- | -- | 51% 146.97K to 221.97K | |
| 13-May-21 4:43 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 12-May-21 | Option Exercise | 35,852 | $4.73 | $169,580.00 | 33% 110.28K to 146.13K | |
| 13-May-21 4:43 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 11-May-21 | Option Exercise | 102,780 | $4.14 | $425,442.00 | 93% 110.28K to 213.06K | |
| 13-May-21 4:43 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 11-May-21 | Market Option Sale | 102,780 | $12.04 | $1,237,470.00 | (48%) 213.06K to 110.28K | |
| 15-Dec-20 5:35 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 11-Dec-20 | Option Exercise | 13,741 | $4.15 | $57,025.20 | 13% 108.06K to 121.8K | |
| 15-Dec-20 5:35 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 11-Dec-20 | Market Option Sale | 13,741 | $7.96 | $109,378.00 | (11%) 121.8K to 108.06K | 5% |
| 08-Dec-20 4:12 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 04-Dec-20 | Option Exercise | 13,741 | $4.15 | $57,025.20 | 13% 108.06K to 121.8K | |
| 08-Dec-20 4:12 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 04-Dec-20 | Market Option Sale | 13,741 | $6.23 | $85,606.40 | (11%) 121.8K to 108.06K | (22%) |
| 18-Nov-19 4:05 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 18-Nov-19 | Private Purchase | 20,000 | $1.45 | $29,000.00 | 24% 82.06K to 102.06K | |
| 03-Jan-19 4:38 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 01-Jan-19 | Payment of Exercise | 423 | $8.07 | $3,413.61 | (< 1%) 77.95K to 77.53K | 7% |
| 04-Dec-18 4:11 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 30-Nov-18 | Option Exercise | 25,000 | $1.42 | $35,500.00 | 26% 97.24K to 122.24K | |
| 04-Dec-18 4:11 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 30-Nov-18 | Market Option Sale | 25,000 | $9.07 | $226,750.00 | (20%) 122.24K to 97.24K | 17% |
| 04-Dec-18 4:11 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 30-Nov-18 | Market Sale | 19,290 | $9.07 | $174,960.00 | (20%) 97.24K to 77.95K | 17% |
| 17-May-18 9:25 AM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 15-May-18 | Payment of Exercise | 3,004 | $5.91 | $17,753.60 | (3%) 98.27K to 95.26K | (27%) |
| 17-May-18 9:25 AM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 15-May-18 | Option Exercise | 12,500 | $1.42 | $17,750.00 | 15% 85.77K to 98.27K | |
| 02-Mar-18 2:21 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 28-Feb-18 | Option Exercise | 6,709 | $3.26 | $21,871.30 | 8% 79.06K to 85.77K | |
| 23-Jan-18 9:12 AM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 20-Jan-18 | Payment of Exercise | 1,961 | $5.59 | $10,962.00 | (2%) 79.09K to 77.13K | (35%) |
| 03-Jan-18 9:13 AM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 01-Jan-18 | Payment of Exercise | 459 | $4.91 | $2,253.69 | (< 1%) 79.55K to 79.09K | (53%) |
| 24-Jan-17 9:28 AM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 20-Jan-17 | Payment of Exercise | 2,599 | $5.95 | $15,464.00 | (3%) 78.1K to 75.5K | (27%) |
| 03-Jan-17 2:13 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 01-Jan-17 | Payment of Exercise | 1,281 | $6.33 | $8,108.73 | (2%) 79.38K to 78.1K | (19%) |
| 16-Sep-16 10:54 AM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 14-Sep-16 | Market Sale | 8,357 | $4.27 | $35,684.40 | (10%) 87.73K to 79.38K | (77%) |
| 03-Mar-16 9:56 AM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 01-Mar-16 | Payment of Exercise | 687 | $2.13 | $1,463.31 | (< 1%) 86.1K to 85.42K | (253%) |
| 01-Feb-16 2:34 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 29-Jan-16 | Option Exercise | 19,368 | $1.42 | $27,502.60 | 29% 65.69K to 85.06K | |
| 22-Jan-16 9:27 AM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 20-Jan-16 | Payment of Exercise | 2,599 | $7.55 | $19,622.50 | (4%) 68.29K to 65.69K | < 1% |
| 05-Jan-16 1:31 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 01-Jan-16 | Payment of Exercise | 1,281 | $10.32 | $13,219.90 | (2%) 69.57K to 68.29K | 27% |
| 22-Jun-15 4:51 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 19-Jun-15 | Market Sale | 3,000 | $15.00 | $45,000.00 | (4%) 71.88K to 68.88K | 50% |
| 03-Mar-15 3:59 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 01-Mar-15 | Payment of Exercise | 1,120 | $10.20 | $11,424.00 | (2%) 73.0K to 71.88K | 26% |
| 22-Jan-15 12:18 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 20-Jan-15 | Payment of Exercise | 2,210 | $11.17 | $24,685.70 | (3%) 74.58K to 72.37K | 33% |
| 05-Jan-15 4:12 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 01-Jan-15 | Grant | 4,800 | -- | -- | 7% 72.23K to 77.03K | |
| 05-Jan-15 4:12 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 01-Jan-15 | Payment of Exercise | 2,453 | $12.16 | $29,828.50 | (3%) 77.03K to 74.58K | 38% |
| 07-Mar-14 4:11 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 04-Mar-14 | Option Exercise | 31,174 | $4.01 | $124,897.00 | 38% 81.18K to 112.36K | |
| 07-Mar-14 4:11 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 04-Mar-14 | Market Option Sale | 31,174 | $12.63 | $393,728.00 | (28%) 112.36K to 81.18K | 40% |
| 07-Mar-14 4:11 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 04-Mar-14 | Market Sale | 9,560 | $12.63 | $120,743.00 | (12%) 81.18K to 71.62K | 40% |
| 07-Mar-14 4:11 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 01-Mar-14 | Payment of Exercise | 1,090 | $11.69 | $12,742.10 | (1%) 82.27K to 81.18K | 36% |
| 04-Feb-14 3:53 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 20-Jan-14 | Grant | 27,000 | -- | -- | 50% 54.49K to 81.49K | |
| 15-Jan-14 8:55 AM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 14-Jan-14 | Payment of Exercise | 1,491 | $10.87 | $16,207.20 | (3%) 55.98K to 54.49K | 31% |
| 15-Jan-14 8:55 AM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 14-Jan-14 | Option Exercise | 13,500 | $1.20 | $16,200.00 | 32% 42.48K to 55.98K | |
| 03-Jan-14 3:52 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 01-Jan-14 | Payment of Exercise | 2,453 | $7.60 | $18,642.80 | (5%) 44.93K to 42.48K | < 1% |